Search for: "APOTEX CORP." Results 141 - 160 of 333
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Feb 2012, 10:56 am by Courtney Minick
In AstraZeneca Pharmaceuticals, L.P. v Apotex Corp., the Court held for defendant generic manufacturers on the grounds that Plaintiff failed to state a 35 U.S.C. 271(e)(2) claim based on defendants’ existing ANDA filings, and claims premised on presumed future labeling amendments were not ripe for adjudication. [read post]
10 Feb 2012, 10:56 am by Courtney Minick
In AstraZeneca Pharmaceuticals, L.P. v Apotex Corp., the Court held for defendant generic manufacturers on the grounds that Plaintiff failed to state a 35 U.S.C. 271(e)(2) claim based on defendants’ existing ANDA filings, and claims premised on presumed future labeling amendments were not ripe for adjudication. [read post]
2 Mar 2010, 5:10 am by Lawrence B. Ebert
Apotex, Inc., 480 F.3d 1348, 1362 (Fed. [read post]
14 May 2019, 11:24 am by Lawrence B. Ebert
Cir. 2014)(quoting Alza Corp. v. [read post]
18 Feb 2020, 4:00 am by Martin Kratz
Pfizer Canada ULC, 2020 FC 1, at para. 48. [12] See Free World Trust, supra, at paragraph 13; Apotex Inc v Wellcome Foundation Ltd, 2002 SCC 77 at paragraph 37, [2002] 4 SCR 153; AstraZeneca Canada Inc v Apotex Inc, 2017 SCC 36 at paragraph 39, [2017] 1 SCR 943 [13] See Free World Trust, supra, at paragraphs 33–43; applied in Seedlings Life Science Ventures, LLC v. [read post]
21 Dec 2010, 10:07 am by Lawrence B. Ebert
Apotex Corp., 403 F.3d1331, 1340-41 (Fed. [read post]
1 Apr 2013, 8:29 am by Gene Quinn
.; Apotex Corp.; and Apotex, Inc. in the United States District Court for the Eastern District of Virginia for infringement of the reissue patent. [read post]